This paper is from China so there are significant differences - they use methimazole rather than carbimazole (very little real difference), and the cost of hospital nights is much, much lower than in the UK (or USA).
However, the reason I am posting is to emphasise that suspected agranulocytosis needs to be investigated immediately. That is, do go to Accident and Emergency, do demand appropriate blood tests, etc.
Catching it as early as possible has the potential for massive savings of costs. A few blood tests which end up showing no issue are far less a cost than a stay in hospital. Don't feel bad about going to A&E. Feel good about being responsible - for your own benefit and for the cost savings to the healthcare system.
Endocr Pract. 2021 Jun 30;S1530-891X(21)01113-7.
doi: 10.1016/j.eprac.2021.06.017. Online ahead of print.
THIONAMIDE-INDUCED AGRANULOCYTOSIS: A RETROSPECTIVE ANALYSIS OF 36 PATIENTS WITH HYPERTHYROIDISM
Dongchun Zhu 1 , Shiqi Zhang 2 , Xi Cao 3 , Quan Xia 1 , Qiu Zhang 2 , Datong Deng 2 , Shan Gao 4 , Haixia Yu 3 , Yaru Liu 3 , Haiyun Zhou 3 , Fangbiao Tao 5 , Xuqun Sun 6
• PMID: 34216800
• DOI: 10.1016/j.eprac.2021.06.017
Abstract
Objective:
Agranulocytosis is a rare but serious adverse drug reaction (ADR) of thionamide antithyroid drugs (ATDs). We explored the characteristics of ADRs in patients with hyperthyroidism.
Methods:
This retrospective study included 3558 inpatients with Graves' disease (GD) treated in a Class A Grade 3 hospital between 2015 and 2019. The clinical presentation and laboratory workup of patients with ATD-induced agranulocytosis were analyzed.
Results:
Agranulocytosis was thought to be caused by ATD in 36 patients. The hospital length of stay (h-LOS) was 12 (10-16) days, and hospitalization costs were approximately $2810.89 (2156.50-4164.67). The median duration of ATD therapy prior to agranulocytosis development was 30 (20-40) days. Fever (83.33%) and sore throat (75%) were the most common symptoms as early signs of agranulocytosis. The lowest neutrophil counts were 0.01 (0.00-0.03) × 109/L and 0.14 (0.02-0.29) × 109/L in the methimazole and propylthiouracil groups, respectively (P = 0.037). The recovery times of agranulocytosis were 9.32 ± 2.89 days and 5.60 ± 4.10 days in the methimazole and propylthiouracil groups, respectively (P = 0.016). Severe agranulocytosis patients required a longer time to recover (P <0.001) and had closer to normal serum thyroxine (T4) and triiodothyronine (T3) concentrations. The interval between the first symptom of agranulocytosis and ATD withdrawal was 1 (0-3) day.
Conclusions:
Agranulocytosis patients needed a long h-LOS and incurred high costs. Methimazole was prone to causing more serious agranulocytosis than propylthiouracil. High thyroid hormone was unlikely to play a role in the ADR. Patient education is important.
Keywords: agranulocytosis; antithyroid drug; hyperthyroidism; methimazole; propylthiouracil.